Javelin Pharmaceuticals, Inc. comments on tender offer extension by Hospira
Javelin Pharmaceuticals, Inc. , a leading developer of novel acute care pain products, commented on the tender offer extension by Hospira, Inc.
Homebuilder M/I Homes Inc. said Thursday it has begun a tender offer to buy back its 6.875 percent senior notes due in 2012.